BUZZ-MindMed因焦虑症治疗的 "突破性疗法 "标签而崛起

Reuters03-07

((自动化翻译由路透提供，请见免责声明 ))

3月7日 - ** 疗法开发商 Mind Medicine 的股价盘前上涨 ~12.5% 至 6.68 美元

** 该公司称 (link)，美国FDA已授予其治疗广泛性焦虑症的药物MM120 "突破性疗法 "资格。

** 突破性疗法 "标签旨在加快对治疗严重疾病或未满足医疗需求的药物的开发和审查。

** 称该公司对该疗法的中期评估试验在 12 周后显示出积极效果

** 截至上次收盘，该公司股价在过去 12 个月中上涨了 77.8

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2417751653?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-07 19:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2417751653","market":"us","top_or_hot":-1,"title":"BUZZ-MindMed因焦虑症治疗的 \"突破性疗法 \"标签而崛起","media":"Reuters","content":"<html><body><p>((自动化翻译由路透提供，请见免责声明 ))</p><p>    3月7日 - ** 疗法开发商 Mind Medicine    的股价盘前上涨 ~12.5% 至 6.68 美元</p><p>** 该公司称 (link)，美国FDA已授予其治疗广泛性焦虑症的药物MM120 \"突破性疗法 \"资格。</p><p>** 突破性疗法 \"标签旨在加快对治疗严重疾病或未满足医疗需求的药物的开发和审查。</p><p>** 称该公司对该疗法的中期评估试验在 12 周后显示出积极效果</p><p>** 截至上次收盘，该公司股价在过去 12 个月中上涨了 77.8</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-MindMed因焦虑症治疗的 \"突破性疗法 \"标签而崛起</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-MindMed因焦虑症治疗的 \"突破性疗法 \"标签而崛起\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-07 19:26 北京时间&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>((自动化翻译由路透提供，请见免责声明 ))    3月7日 - ** 疗法开发商 Mind Medicine    的股价盘前上涨 ~12.5% 至 6.68 美元** 该公司称 (link)，美国FDA已授予其治疗广泛性焦虑症的药物MM120 \"突破性疗法 \"资格。** 突破性疗法 \"标签旨在加快对治疗严重疾病或未满足医疗需求的药物的开发和审查。** 称该公司对该疗法的中期评估试验在 12 ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNMD","symbol_name":"Mind Medicine (MindMed) Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2417751653","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2417751653","pubTimestamp":1709810792,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"((自动化翻译由路透提供，请见免责声明 ))    3月7日 - ** 疗法开发商 Mind Medicine    的股价盘前上涨 ~12.5% 至 6.68 美元** 该公司称 (link)，美国FDA已授予其治疗广泛性焦虑症的药物MM120 \"突破性疗法 \"资格。** 突破性疗法 \"标签旨在加快对治疗严重疾病或未满足医疗需求的药物的开发和审查。** 称该公司对该疗法的中期评估试验在 12 周后显示出积极效果** 截至上次收盘，该公司股价在过去 12 个月中上涨了 77.8","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc.","BUZZ":"VanEck Social Sentiment ETF","BK4007":"制药","BK4547":"WSB热门概念"},"translate_title":"BUZZ-MindMed rose with the label of \"breakthrough therapy\" for anxiety treatment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BUZZ":1,"MNMD":0.9},"content_text":"((自动化翻译由路透提供，请见免责声明 ))    3月7日 - ** 疗法开发商 Mind Medicine    的股价盘前上涨 ~12.5% 至 6.68 美元** 该公司称 (link)，美国FDA已授予其治疗广泛性焦虑症的药物MM120 \"突破性疗法 \"资格。** 突破性疗法 \"标签旨在加快对治疗严重疾病或未满足医疗需求的药物的开发和审查。** 称该公司对该疗法的中期评估试验在 12 周后显示出积极效果** 截至上次收盘，该公司股价在过去 12 个月中上涨了 77.8","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2417751653"}